DE2821966A1 - Spiro-hydantoinderivate und ihre verwendung - Google Patents
Spiro-hydantoinderivate und ihre verwendungInfo
- Publication number
- DE2821966A1 DE2821966A1 DE19782821966 DE2821966A DE2821966A1 DE 2821966 A1 DE2821966 A1 DE 2821966A1 DE 19782821966 DE19782821966 DE 19782821966 DE 2821966 A DE2821966 A DE 2821966A DE 2821966 A1 DE2821966 A1 DE 2821966A1
- Authority
- DE
- Germany
- Prior art keywords
- spiro
- dione
- acid
- compounds
- fluoro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Description
Analyse auf C„ ,,Kq | J2 aÄ *™v v/— | 5*C23:: | 261T2 | E = 6 | OH: | 1Ϊ | = 8 | ,28 5c |
berechnet: | C | = 63, | 88 | E = 6 | ,'12 | IT | = 8 | ,22 >. |
gefunden: | C | = 63, | 60 | ,07 | ||||
b ere elm et: | C | = 55 | ,59 | H = 5,84 | it | = 11,86 |
gefunden: | C | = 55 |
V _ T. PP
*.*. — ^,, —^ |
iT | = 11,52 | |
gefunden:
gefunden:
refundeii:
Tabelle | χ | 58 | Hemmung ( 10"6I-I |
prozentuale 0""1K 1O~% |
100 | 52 | |
35 | 63 | 93 | |
100 | 77 | 23 | |
88 | 80 | 66 | |
81 | 65 | 76 | |
89 | 11 | ||
87 |
Claims (8)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/799,586 US4130714A (en) | 1977-05-23 | 1977-05-23 | Hydantoin therapeutic agents |
Publications (2)
Publication Number | Publication Date |
---|---|
DE2821966A1 true DE2821966A1 (de) | 1978-11-30 |
DE2821966C2 DE2821966C2 (de) | 1983-06-01 |
Family
ID=25176274
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2821966A Expired DE2821966C2 (de) | 1977-05-23 | 1978-05-19 | Rechtsdrehendes Isomer des 6-Fluor-spiro[chroman-4,4'-imidazolidin]-2',5'-dions sowie der Basensalze hiervon und deren Verwendung |
DE2858042A Expired DE2858042C2 (de) | 1977-05-23 | 1978-05-19 | Rechtsdrehendes Isomer eines asymmetrischen Spirohydantoins sowie der Basensalze hiervon und ihre Verwendung |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2858042A Expired DE2858042C2 (de) | 1977-05-23 | 1978-05-19 | Rechtsdrehendes Isomer eines asymmetrischen Spirohydantoins sowie der Basensalze hiervon und ihre Verwendung |
Country Status (37)
Country | Link |
---|---|
US (1) | US4130714A (de) |
JP (1) | JPS6035350B2 (de) |
AR (1) | AR219531A1 (de) |
AT (1) | AT357170B (de) |
AU (1) | AU499518B1 (de) |
BE (1) | BE867248A (de) |
CA (1) | CA1088073A (de) |
CH (1) | CH631455A5 (de) |
CS (1) | CS200550B2 (de) |
DD (1) | DD137107A5 (de) |
DE (2) | DE2821966C2 (de) |
DK (1) | DK147941C (de) |
EG (1) | EG13691A (de) |
ES (1) | ES470070A1 (de) |
FI (1) | FI62838C (de) |
FR (1) | FR2392024A1 (de) |
GB (1) | GB1572688A (de) |
GR (1) | GR68694B (de) |
HK (1) | HK53981A (de) |
HU (1) | HU177718B (de) |
IE (1) | IE47273B1 (de) |
IL (1) | IL54754A (de) |
IN (1) | IN147854B (de) |
IT (1) | IT1096306B (de) |
KE (1) | KE3168A (de) |
LU (1) | LU79685A1 (de) |
MY (1) | MY8200156A (de) |
NL (1) | NL7804158A (de) |
NO (1) | NO150206C (de) |
NZ (1) | NZ187334A (de) |
PH (1) | PH13828A (de) |
PL (1) | PL110460B1 (de) |
PT (1) | PT68071B (de) |
SE (1) | SE437375B (de) |
SU (1) | SU873885A3 (de) |
YU (1) | YU40829B (de) |
ZA (1) | ZA782919B (de) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1088945A (en) * | 1976-10-18 | 1980-11-04 | Pfizer Limited | Hydantoin derivatives as therapeutic agents |
US4181728A (en) * | 1978-11-16 | 1980-01-01 | Pfizer Inc. | Spiro-polycyclicimidazolidinedione derivatives |
US4181729A (en) * | 1979-03-21 | 1980-01-01 | Pfizer Inc. | Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives |
US4210667A (en) * | 1979-04-19 | 1980-07-01 | Pfizer Inc. | Pharmaceutical preparations containing coumarin carboxylic acid derivatives |
AU532110B2 (en) * | 1979-11-13 | 1983-09-15 | Ici Ltd. | Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives |
US4248882A (en) * | 1980-02-12 | 1981-02-03 | Pfizer Inc. | Treating diabetes-associated complications with hydantoin amines |
US4286098A (en) * | 1980-03-28 | 1981-08-25 | Pfizer Inc. | Process for the preparation of chiral hydantoins |
JPS5745185A (en) * | 1980-07-21 | 1982-03-13 | Eisai Co Ltd | Hydantoin derivative and its preparation |
US4419521A (en) * | 1981-11-12 | 1983-12-06 | Pfizer Inc. | 6-Halo-4-chromanamines useful as intermediates to make chiral hydantoins |
JPS58124788A (ja) * | 1982-01-20 | 1983-07-25 | Eisai Co Ltd | 光学活性ヒダントイン誘導体,その製造方法ならびにそれを含有する治療用薬剤 |
US4438272A (en) | 1982-04-15 | 1984-03-20 | Alcon Laboratories, Inc. | Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones |
US4436745A (en) | 1982-04-15 | 1984-03-13 | Alcon Laboratories, Inc. | Method of inhibiting aldose reductase activity |
US4540700A (en) * | 1982-04-15 | 1985-09-10 | Alcon Laboratories, Inc. | Treatment of diabetic complications with certain spiro-imidazolidine-diones |
US4464385A (en) * | 1982-04-15 | 1984-08-07 | Alcon Laboratories, Inc. | Treatment of diabetic complications with hydantoins |
US4431828A (en) * | 1982-11-10 | 1984-02-14 | Pfizer Inc. | Regeneration of 6-fluoro-4-chromanone from by-products in the synthesis of sorbinil |
US4528387A (en) * | 1982-11-10 | 1985-07-09 | Pfizer Inc. | Sorbinil by optical resolution of precursor 6-fluoro-4-ureidochroman-4-carboxylic acid |
US4556670A (en) * | 1982-12-06 | 1985-12-03 | Pfizer Inc. | Spiro-3-hetero-azolones for treatment of diabetic complications |
US4474967A (en) * | 1983-04-27 | 1984-10-02 | Pfizer Inc. | 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione |
US5153211A (en) * | 1983-09-14 | 1992-10-06 | Alcon Laboratories, Inc. | Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase |
US4537892A (en) * | 1983-09-14 | 1985-08-27 | Alcon Laboratories, Inc. | Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase |
EP0159143B1 (de) * | 1984-03-23 | 1987-12-16 | Pfizer Inc. | Spiro-Indene und Spiro-1,2-Dihydro-Naphthalene für die Behandlung von diabetischen Komplikationen |
US4600717A (en) * | 1984-04-11 | 1986-07-15 | Alcon Laboratories, Inc. | Aldose reductase inhibitors useful in ophthalmic wound healing |
US4717725A (en) * | 1984-04-11 | 1988-01-05 | Alcon Laboratories, Inc. | Ophthalmic wound healing with aldose reductase inhibitors |
JPH06772B2 (ja) * | 1984-07-09 | 1994-01-05 | 鐘淵化学工業株式会社 | 3―(4―フルオロフエノキシ)プロピオニトリルを用いる6―フルオロ―4―クロマノンの製造法 |
US4680306A (en) * | 1984-07-20 | 1987-07-14 | Pfizer Inc. | Sprio-imidazolones for treatment of diabetes complications |
US4656169A (en) * | 1984-08-14 | 1987-04-07 | Pfizer Inc. | Tetracyclic spiro-hydantoin aldose reductase inhibitors and compositions |
ATE37371T1 (de) * | 1984-08-20 | 1988-10-15 | Pfizer | Verfahren zur herstellung asymmetrischer hydantoine. |
US4620019A (en) * | 1984-08-23 | 1986-10-28 | Pfizer Inc. | S-6-fluoro-4-aminochroman-4-carboxylic acid derivatives useful as intermediates for sorbinil |
US4609663A (en) * | 1984-09-11 | 1986-09-02 | Alcon Laboratories, Inc. | Aldose reductase inhibitors useful in glaucoma therapy |
US4551542A (en) * | 1984-09-26 | 1985-11-05 | Pfizer Inc. | Regeneration of 6-fluoro-4-chromanone from 6-fluoro-4-ureidochroman-4-carboxylic acid |
US4966911A (en) * | 1984-11-20 | 1990-10-30 | Washington Research Foundation | Immunoregulatory agents |
US5340829A (en) * | 1984-11-20 | 1994-08-23 | Washington Research Foundation | Immunoregulatory agents |
JPS61200991A (ja) * | 1985-03-04 | 1986-09-05 | Sanwa Kagaku Kenkyusho:Kk | スピロ―3―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤 |
WO1986007353A1 (en) | 1985-06-14 | 1986-12-18 | Pfizer Inc. | Intermediate in the production of an asymmetric hydantoin |
JPS627654U (de) * | 1985-06-26 | 1987-01-17 | ||
WO1987004344A1 (en) * | 1986-01-17 | 1987-07-30 | Pfizer Inc. | Hydroxyacetic acid derivatives for the treatment of diabetic complications |
JPS6357588A (ja) * | 1986-08-28 | 1988-03-12 | Sanwa Kagaku Kenkyusho Co Ltd | ヒダントイン誘導体、その塩並びに該化合物を有効成分とする糖尿病合併症の予防及び治療剤 |
AU598366B2 (en) * | 1987-03-20 | 1990-06-21 | Alcon Laboratories, Inc. | Use of aldose reductase inhibitors to enhance insulin sensitivity in diabetes |
US4841079A (en) * | 1987-08-07 | 1989-06-20 | Pfizer, Inc. | Process for the production of asymmetric hydantoins |
US4952694A (en) * | 1988-07-27 | 1990-08-28 | Pfizer Inc. | Novel resolution process for racemic spiro-hydantoins |
US5006657A (en) * | 1988-07-27 | 1991-04-09 | Pfizer Inc. | Intermediates in a resolution process for racemic spiro hydantoins |
AU617541B2 (en) * | 1988-10-20 | 1991-11-28 | Wyeth | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
EP0536119A4 (en) * | 1989-02-10 | 1993-08-04 | Washington Research Foundation | Immunoregulatory agents |
US4980357A (en) * | 1990-03-01 | 1990-12-25 | Pfizer Inc. | Azolidinedione derivatives |
US5039672A (en) * | 1990-04-05 | 1991-08-13 | Pfizer Inc. | Heterocyclic compounds as aldose reductase inhibitors |
US5236945A (en) * | 1990-06-11 | 1993-08-17 | Pfizer Inc. | 1H-indazole-3-acetic acids as aldose reductase inhibitors |
US5206367A (en) * | 1992-02-18 | 1993-04-27 | Pfizer Inc. | Preparation of optically active spiro-hydantoins |
AU683620B2 (en) * | 1992-09-28 | 1997-11-20 | Pfizer Inc. | Substituted pyrimidines for control of diabetic complications |
US5521208A (en) * | 1993-07-29 | 1996-05-28 | Alcon Laboratories, Inc. | Compositions and methods for the treatment of the metabolically impaired and for improved compliance |
WO1998046243A2 (en) * | 1997-04-15 | 1998-10-22 | Csir | Pharmaceutical compositions having appetite suppressant activity |
GB2355657B (en) * | 1999-10-27 | 2004-07-28 | Phytopharm Plc | Inhibitors Of Gastric Acid Secretion |
GB2363985B (en) | 2000-06-30 | 2004-09-29 | Phytopharm Plc | Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use |
EP1337272A2 (de) | 2000-11-30 | 2003-08-27 | Pfizer Products Inc. | Kombination von gaba agonisten und aldose reductase inhibitoren |
US20110092566A1 (en) * | 2004-11-19 | 2011-04-21 | Srivastava Satish K | Treatment of cancer with aldose reductase inhibitors |
US8158667B2 (en) | 2006-08-21 | 2012-04-17 | Kador Peter F | Topical treatment of cataracts in dogs |
ES2371393T3 (es) | 2007-03-12 | 2011-12-30 | Zadec Aps | Extracto antidiabético de rooibos. |
EP2848252A3 (de) | 2007-03-23 | 2015-06-17 | The Board of Regents of the University of Texas System | Aldose-Reduktase-Inhibitoren zur Behandlung von Uveitis |
US20090270490A1 (en) * | 2008-04-24 | 2009-10-29 | The Board Of Regents Of The University Of Texas System | Methods involving aldose reductase inhibition |
CA2822672C (en) | 2010-12-23 | 2018-06-05 | The Board Of Regents Of The University Of Texas System | Methods for treating copd |
UA118035C2 (uk) * | 2013-10-07 | 2018-11-12 | Сінгента Партісіпейшнс Аг | Гербіцидні сполуки |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2683718A (en) * | 1952-01-11 | 1954-07-13 | Searle & Co | Spiro-[xanthene-9, 4'-imidazolidine]-2, 5-dione |
DE1135915B (de) * | 1961-06-29 | 1962-09-06 | Asta Werke Ag Chem Fab | Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine |
CA1088945A (en) * | 1976-10-18 | 1980-11-04 | Pfizer Limited | Hydantoin derivatives as therapeutic agents |
-
1977
- 1977-05-23 US US05/799,586 patent/US4130714A/en not_active Expired - Lifetime
-
1978
- 1978-03-30 SE SE7803626A patent/SE437375B/sv not_active IP Right Cessation
- 1978-04-15 IN IN272/DEL/78A patent/IN147854B/en unknown
- 1978-04-19 PH PH21026A patent/PH13828A/en unknown
- 1978-04-19 NL NL7804158A patent/NL7804158A/xx active Search and Examination
- 1978-05-11 CS CS783021A patent/CS200550B2/cs unknown
- 1978-05-13 JP JP53057064A patent/JPS6035350B2/ja not_active Expired
- 1978-05-16 YU YU1169/78A patent/YU40829B/xx unknown
- 1978-05-16 PL PL1978206826A patent/PL110460B1/pl unknown
- 1978-05-17 SU SU782616255A patent/SU873885A3/ru active
- 1978-05-17 HU HU78PI625A patent/HU177718B/hu not_active IP Right Cessation
- 1978-05-18 DD DD78205450A patent/DD137107A5/de unknown
- 1978-05-18 GB GB20352/78A patent/GB1572688A/en not_active Expired
- 1978-05-18 AR AR272227A patent/AR219531A1/es active
- 1978-05-19 DE DE2821966A patent/DE2821966C2/de not_active Expired
- 1978-05-19 DE DE2858042A patent/DE2858042C2/de not_active Expired
- 1978-05-19 AT AT365378A patent/AT357170B/de not_active IP Right Cessation
- 1978-05-19 CA CA303,740A patent/CA1088073A/en not_active Expired
- 1978-05-19 BE BE187841A patent/BE867248A/xx not_active IP Right Cessation
- 1978-05-20 EG EG320/78A patent/EG13691A/xx active
- 1978-05-20 GR GR56282A patent/GR68694B/el unknown
- 1978-05-22 CH CH552778A patent/CH631455A5/fr not_active IP Right Cessation
- 1978-05-22 NZ NZ187334A patent/NZ187334A/en unknown
- 1978-05-22 DK DK226778A patent/DK147941C/da not_active IP Right Cessation
- 1978-05-22 LU LU79685A patent/LU79685A1/xx unknown
- 1978-05-22 IE IE1015/78A patent/IE47273B1/en not_active IP Right Cessation
- 1978-05-22 IT IT23672/78A patent/IT1096306B/it active
- 1978-05-22 IL IL54754A patent/IL54754A/xx not_active IP Right Cessation
- 1978-05-22 PT PT68071A patent/PT68071B/pt unknown
- 1978-05-22 FI FI781613A patent/FI62838C/fi not_active IP Right Cessation
- 1978-05-22 AU AU36328/78A patent/AU499518B1/en not_active Expired
- 1978-05-22 ES ES470070A patent/ES470070A1/es not_active Expired
- 1978-05-22 ZA ZA00782919A patent/ZA782919B/xx unknown
- 1978-05-22 NO NO781769A patent/NO150206C/no unknown
- 1978-05-22 FR FR7815032A patent/FR2392024A1/fr active Granted
-
1981
- 1981-10-15 KE KE3168A patent/KE3168A/xx unknown
- 1981-11-05 HK HK539/81A patent/HK53981A/xx unknown
-
1982
- 1982-12-30 MY MY156/82A patent/MY8200156A/xx unknown
Non-Patent Citations (1)
Title |
---|
NICHTS-ERMITTELT * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2821966A1 (de) | Spiro-hydantoinderivate und ihre verwendung | |
DE2901477C2 (de) | Spirothienohydantoinderivate und diese enthaltende Arzneimittel | |
DE69632152T2 (de) | N-substituierte dioxothiazolidyl-benzamid-derivate und verfahren zu ihrer herstellung | |
DE3128606C2 (de) | ||
DE3005164C2 (de) | 1,1-Dioxopenicillanoyloxymethyl-6-(D-α-amino-α-phenylacetamido)-penicillanat, Verfahren zu seiner Herstellung und es enthaltendes Arzneimittel | |
DE2759927C2 (de) | Spiro-hydantoin-Verbindungen | |
DE2351412C2 (de) | 2,2-Disubstituierte 1-Oxo-5-indanyloxy-carbonsäuren, Verfahren zu deren Herstellung und Spaltung racemischer Gemische, sowie diese enthaltende Arzneimittel | |
DE2933441A1 (de) | Neue spiro-oxazolidindione und solche verbindungen enthaltende arzneimittel | |
DE2946037A1 (de) | Spiro-polycycloimidazolidindion-derivate und diese enthaltende arzneimittel | |
EP0149840B1 (de) | Substituierte 5,11-Dihydro-6H-dibenz(b,e)azepin-6-one, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
DE4200145A1 (de) | 7,10-epoxy-oxacyclododecan-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
DE3038966C2 (de) | ||
DE2234651A1 (de) | Eckige klammer auf 1-(p-chlorbenzoyl)5-methoxy-2-methyl-3-indol eckige klammer zu acetoxyessigsaeure, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln | |
EP0010156B1 (de) | 6-Arylpyridazin-3-one, diese enthaltende pharmazeutische Zubereitungen und Verfahren zu ihrer Herstellung | |
DE3041097A1 (de) | Substituierte oxocarbonsaeuren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel | |
EP0006114B1 (de) | 7-Methoxy-5-oxo-5H-thiazolo(2,3-b)chinazolin-2-carbonsäure und deren pharmazeutisch verwendbare Salze. Verfahren zu deren Herstellung und sie enthaltende Arzneimittel | |
DE2448438A1 (de) | 2-substituierte und 2,2-disubstituierte eckige klammer auf 1,3-dioxoindanyloxy(oder -thio) eckige klammer zu -alkancarbonsaeuren und verfahren zur herstellung derselben | |
DE2647041C2 (de) | 3-Aminomethylen-6,7-dimethoxy-2- methyl-4-oxo-1,2,3,4-tetrahydro-1-chinolincarbonsäureäthylester | |
DE60116514T2 (de) | Amlodipinhemimaleat | |
CH643830A5 (de) | Bis-moranolin-derivate. | |
EP0313935B1 (de) | Enolether von 6-Chlor-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazin-3-carbonsäureamid-1,1-dioxid, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung | |
DE2106038C3 (de) | 2-Imidazolin-2-ylamino-benzo [b] thiophene und diese enthaltende pharmazeutische Präparate | |
DE2419198A1 (de) | Pyridincarboxamidsulfonylharnstoffe als hypoglykaemische mittel | |
DE3337925C2 (de) | N-(6-Aminopurinyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazin-3-carboxamid-1,1-dioxid, Verfahren zu dessen Herstellung und seine Verwendung | |
DE2355536A1 (de) | Adeninderivate und verfahren zu ihrer herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OAP | Request for examination filed | ||
OD | Request for examination | ||
OI | Miscellaneous see part 1 | ||
8172 | Supplementary division/partition in: |
Ref country code: DE Ref document number: 2858042 Format of ref document f/p: P |
|
AH | Division in |
Ref country code: DE Ref document number: 2858042 Format of ref document f/p: P |
|
Q171 | Divided out to: |
Ref country code: DE Ref document number: 2858042 |
|
8125 | Change of the main classification |
Ipc: C07D491/107 |
|
8126 | Change of the secondary classification |
Ipc: ENTFAELLT |
|
8126 | Change of the secondary classification |
Free format text: A61K 31/41 A61K 31/35 |
|
AF | Is addition to no. |
Ref country code: DE Ref document number: 2746244 Format of ref document f/p: P |
|
AF | Is addition to no. |
Ref country code: DE Ref document number: 2746244 Format of ref document f/p: P |
|
D2 | Grant after examination | ||
8364 | No opposition during term of opposition | ||
AH | Division in |
Ref country code: DE Ref document number: 2858042 Format of ref document f/p: P |
|
8340 | Patent of addition ceased/non-payment of fee of main patent |